| Gene symbol | TTR | Synonyms | ATTR, CTS, CTS1, HEL111, HsT2651, PALB, TBPA, TTN | Type of gene | protein-coding |
| Chromosome | 18 | Map location | 18q12.1 | dbXrefs | |
| Gene perturbation-related omics dataset | PerturbAtlas | ||||
| Description | transthyretin | ||||
| GTO ID | GTC2306 |
| Trial ID | NCT04270058 |
| Disease | Transthyretin Amyloid Cardiomyopathy |
| Altered gene | TTR |
| Therapeutic/Target gene | Target gene |
| Therapy | ASO |
| Treatment | ISIS 416858|IONIS-FXIRX|FXI-ASO|ISIS-FXI Rx|BAY2306001||BAY2306001|Fesomersen |
| Recruitment status | Recruiting |
| Title | Pregnancy Surveillance Program of Women and Infants Exposed to TEGSEDI During Pregnancy |
| Year | 2020 |
| Country | United States |
| Company sponsor | Akcea Therapeutics |
| Other ID(s) | TEG4005 |
| Vector information | |||
|
|||
| Cohort1: inotersen | |||||
|
|||||
| Cohort2: No Intervention | |||||
|
|||||